TORONTO, Sept. 22, 2022 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”) has successfully exported psilocybin mushrooms to Psilo Scientific Ltd. in Canada. Psilo Scientific, a wholly owned subsidiary of Filament Health Corp., is an exclusively natural psychedelic drug discovery and extraction company. Psyence received a Health Canada import permit…


Previous articleOptimi Health, ATMA Journey Centers To Proceed With Phase I Natural Psilocybin and MDMA Clinical Trial Application to Health Canada
Next articleNuminus Expands Ketamine Therapy for Mental Health in Montreal and announces new brand awareness initiativesUSA – EnglishUSA – EnglishUSA – EnglishEspaña – españolLatin America – español